ECG vs MTZ: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
MTZ is the larger of the two ($14.45B market cap): the incumbent the market prices for continued execution (14.68x forward earnings, beta 1.92). ECG is the smaller challenger ($4.35B), cheaper on forward earnings (12.18x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
ECG vs MTZ: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | ECG | MTZ | What it tells you |
|---|---|---|---|
| Market cap | $4.35B | $14.45B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 12.18 | 14.68 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 15.07 | 29.36 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 2.48 | 1.92 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 15% of range | 11% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 5.03 | 3.46 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: ECG is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how ECG and MTZ affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ECG and MTZ share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ECG and MTZ exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Everus Construction Group (ECG) do?
Everus Construction Group is a specialty construction and infrastructure services company headquartered in Bismarck, North Dakota, with about 9,400 employees. It operates through roughly 15 wholly owned operating companies that go to market under local brands, organized into two segments. The Electrical & Mechanical (E&M) segment installs and maintains electrical and communication wiring, fire-suppression systems, mechanical piping, and renewables infrastructure for commercial, industrial, and public customers. The Transmission & Distribution (T&D) segment builds and maintains overhead and underground electrical, gas, and communication lines, plus transportation lighting, and manufactures line-construction tools and equipment. A major growth driver is data center construction, where the company cites more than 14 years of experience and strong, visible demand from large customers.
What does MasTec (MTZ) do?
MasTec (NYSE: MTZ) is a Coral Gables, Florida based engineering and construction firm that builds and maintains large-scale infrastructure across four segments: Communications (wireless and wireline/fiber), Power Delivery (utility transmission and distribution), Pipeline Infrastructure (natural gas installation and maintenance), and Clean Energy and Infrastructure (renewables engineering, construction, and heavy civil). The company works for utilities, telecom carriers, energy operators, and government customers, and grows both organically and through acquisitions such as the roughly $1.65 billion Superior Group deal, which closed in July 2026 and adds electrical contracting for data centers and other critical facilities.
ECG vs MTZ: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- ECG drivers: Data center and electrification demand; Record backlog and a beat-and-raise year.
- MTZ drivers: Record backlog and demand acceleration; Grid, data-center, and electrification tailwinds.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: As a construction contractor, Everus is cyclical and sensitive to interest rates, project financing, and customer capital-spending cycles, so a slowdown in data center or infrastructure investment would hit new bookings. For MTZ, masTec is cyclical and project-based, so revenue and margins can swing with customer capital budgets, permitting delays, weather, and the timing of large contracts.
ECG or MTZ: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ECG if you believe its drivers more; MTZ if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ECG and MTZ guides.
ECG vs MTZ: the full fundamentals
ECG. Figures are approximate and tied to the asOf date; verify live numbers before acting. After falling from a 52-week high near $172, Everus trades at ~22x trailing and ~18x forward earnings and ~16x EV/EBITDA, a far smaller premium to the construction median than the mid-30s P/E it carried in July. The early-November third-quarter report, where consensus is ~$1.34 EPS, is the next test of whether backlog conversion and margins justify a rebound.
MTZ. The steep autumn decline has reset the multiple: at ~$190 on October 16, 2026 MasTec trades near 30 times trailing earnings and about 15 times consensus 2027 EPS of ~$12.38, versus a trailing P/E in the 60s when this page was first written, and at under 1 times sales. Management's raised guidance of about $9.30 of 2026 adjusted EPS has not changed, so the debate has moved to cash conversion and debt after negative first-half free cash flow and the Superior Group purchase. Third quarter results on October 29, 2026 (consensus ~$2.97 EPS on ~$4.94 billion revenue) are the next data point.
Headline figures (approximate, October 2026): ECG shows revenue (ttm) ~$4.27 billion, up ~34% in the latest quarter, net income (ttm) ~$254 million (net margin ~6.0%), eps (trailing / 2026 consensus) ~$4.97 / ~$5.31, backlog ~$4.55 billion after Q2 2026, up ~53%; MTZ shows revenue (ttm) ~$16.1B, q2 2026 revenue ~$4.4B (up ~23% YoY), q2 2026 adjusted eps ~$2.22 (vs ~$2.23 est.), operating / net margin (ttm) ~5.4% / ~3.1%.
The bottom line: ECG vs MTZ
ECG and MTZ are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ECG and MTZ exposure against your real portfolio. It is not an investment adviser.
Wondering how ECG or MTZ fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Everus Construction Group
Ask Walnut's AI anything about ECG and see how it fits what you own.
FAQ
What is the difference between ECG and MTZ?
+
Everus Construction Group is a specialty construction and infrastructure services company headquartered in Bismarck, North Dakota, with about 9,400 employees. MasTec (NYSE: MTZ) is a Coral Gables, Florida based engineering and construction firm that builds and maintains large-scale infrastructure across four segments: Communications (wireless and wireline/fiber), Power Delivery (utility transmission and distribution), Pipeline Infrastructure (natural gas installation and maintenance), and Clean Energy and Infrastructure (renewables engineering, construction, and heavy civil). They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is ECG or MTZ the better stock?
+
Neither is universally better. MTZ is the larger incumbent; ECG is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, ECG or MTZ?
+
On forward P/E (as of November 2026), ECG trades at 12.18x and MTZ at 14.68x, so ECG is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both ECG and MTZ?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of ECG vs MTZ?
+
ECG: As a construction contractor, Everus is cyclical and sensitive to interest rates, project financing, and customer capital-spending cycles, so a slowdown in data center or infrastructure investment would hit new bookings. Much of the recent optimism is tied to data center demand, which concentrates the business around a small set of large customers and a single hot end market that could cool; the ~19% three-month drawdown into October 2026 shows how quickly sentiment on that theme can swing. Fixed-price and unit-price contracts carry cost-overrun, labor-availability, and supply-chain risk that can compress margins. As a recent spinoff, the company has a short standalone public track record, and its acquisitive strategy (two cash deals totaling roughly $450 million) adds integration risk and uses balance-sheet capacity, with ~$364 million of debt against ~$158 million of cash at mid-2026. Finally, the shares still trade above traditional construction peers, which leaves less room for disappointment if growth slows. MTZ: MasTec is cyclical and project-based, so revenue and margins can swing with customer capital budgets, permitting delays, weather, and the timing of large contracts. Even after a ~46% three-month drop to ~$190 on October 16, 2026, the shares trade near 30 times trailing earnings (about 15 times forward estimates), and the selloff shows how quickly sentiment can reverse on a contractor priced for growth. The company carries ~$3.2 billion of debt against ~$316 million of cash, first-half 2026 free cash flow was about -$48 million, and net debt rose to ~$2.42 billion at June 30 before the Superior Group acquisition closed in July, adding integration and balance-sheet risk. Fixed-price contracts expose it to cost overruns, and a handful of large customers and projects can concentrate outcomes. Shifts in energy, telecom, or renewable-subsidy policy could also alter demand across its segments.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ECG or MTZ; figures are approximate and dated (as of November 2026). Verify current data before investing.